{"id":123031,"date":"2025-06-12T16:03:21","date_gmt":"2025-06-12T09:03:21","guid":{"rendered":"https:\/\/hmm88i.com\/drug\/?post_type=product&p=123031"},"modified":"2025-07-24T13:12:57","modified_gmt":"2025-07-24T06:12:57","slug":"simponi-iv","status":"publish","type":"product","link":"https:\/\/hmm88i.com\/drug\/simponi-iv\/","title":{"rendered":"Simponi IV 50 mg\/4 mL"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng<\/a> s\u1ebd gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n s\u1ea3n ph\u1ea9m thu\u1ed1c Simponi IV<\/a> \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi Cilag AG, c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 760410037223.<\/strong><\/p>\n

Simponi IV l\u00e0 thu\u1ed1c g\u00ec?<\/h2>\n

Th\u00e0nh ph\u1ea7n<\/h3>\n

Simponi IV<\/strong> l\u00e0 thu\u1ed1c ti\u00eam truy\u1ec1n ch\u1ee9a ho\u1ea1t ch\u1ea5t Golimumab (d\u1ea1ng t\u00e1i t\u1ed5 h\u1ee3p ng\u01b0\u1eddi): 50 mg\/4 mL<\/p>\n

D\u1ea1ng b\u00e0o ch\u1ebf: Dung d\u1ecbch \u0111\u1eadm \u0111\u1eb7c \u0111\u1ec3 truy\u1ec1n t\u0129nh m\u1ea1ch.<\/p>\n

\"Simponi
Simponi IV \u0111i\u1ec1u tr\u1ecb vi\u00eam kh\u1edbp d\u1ea1ng th\u1ea5p<\/figcaption><\/figure>\n

Tr\u00ecnh b\u00e0y<\/h3>\n

S\u0110K: 760410037223<\/p>\n

Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 1 l\u1ecd.<\/p>\n

Xu\u1ea5t x\u1ee9: Th\u1ee5y S\u0129.<\/p>\n

H\u1ea1n s\u1eed d\u1ee5ng: 36 th\u00e1ng.<\/p>\n

T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Simponi IV<\/h2>\n

C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/h3>\n

Thu\u1ed1c Simponi<\/strong> I.V. ch\u1ee9a Golimumab – m\u1ed9t lo\u1ea1i kh\u00e1ng th\u1ec3 \u0111\u01a1n d\u00f2ng th\u1ec3 hi\u1ec7n kh\u1ea3 n\u0103ng g\u1eafn \u0111\u1eb7c hi\u1ec7u v\u1edbi TNF-alpha, m\u1ed9t cytokine ch\u1ee7 y\u1ebfu g\u00e2y vi\u00eam trong nhi\u1ec1u b\u1ec7nh t\u1ef1 mi\u1ec5n.
\nVi\u1ec7c \u1ee9c ch\u1ebf TNF-alpha gi\u00fap: gi\u1ea3m c\u00e1c d\u1ea5u hi\u1ec7u vi\u00eam t\u1ea1i m\u00f4 kh\u1edbp v\u00e0 \u0111\u01b0\u1eddng ti\u00eau h\u00f3a, ng\u0103n ng\u1eeba t\u1ed5n th\u01b0\u01a1ng m\u00f4 l\u00e2u d\u00e0i, l\u00e0m ch\u1eadm ti\u1ebfn tri\u1ec3n b\u1ec7nh.<\/p>\n

Simponi I.V. l\u00e0 m\u1ed9t d\u1ea1ng sinh h\u1ecdc t\u00e1c \u0111\u1ed9ng tr\u1ef1c ti\u1ebfp \u0111\u1ebfn c\u01a1 ch\u1ebf b\u1ec7nh h\u1ecdc, th\u01b0\u1eddng \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh khi c\u00e1c li\u1ec7u ph\u00e1p truy\u1ec1n th\u1ed1ng kh\u00f4ng hi\u1ec7u qu\u1ea3 ho\u1eb7c kh\u00f4ng dung n\u1ea1p \u0111\u01b0\u1ee3c.<\/p>\n

\u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/h2>\n

N\u1ed3ng \u0111\u1ed9 Golimumab \u1ed5n \u0111\u1ecbnh \u0111\u1ea1t \u0111\u01b0\u1ee3c sau 3-5 li\u1ec1u ti\u00eam truy\u1ec1n.<\/p>\n

Golimumab c\u00f3 th\u1eddi gian b\u00e1n th\u1ea3i k\u00e9o d\u00e0i (kho\u1ea3ng 14 ng\u00e0y), gi\u00fap duy tr\u00ec t\u00e1c d\u1ee5ng \u0111i\u1ec1u tr\u1ecb li\u00ean t\u1ee5c gi\u1eefa c\u00e1c l\u1ea7n truy\u1ec1n.<\/p>\n

Thu\u1ed1c Simponi IV \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/h2>\n

Simponi I.V. \u0111\u01b0\u1ee3c d\u00f9ng \u0111\u1ec3 \u0111i\u1ec1u tr\u1ecb cho ng\u01b0\u1eddi l\u1edbn trong c\u00e1c t\u00ecnh tr\u1ea1ng:<\/p>\n